ChronVac-C/TG-4040 prime-boost vaccine (ChronTech/Inovio/Transgene)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameChronVac-C/TG-4040 prime-boost vaccine (ChronTech/Inovio/Transgene)
Drug Alias NameHCV prime-boost vaccine (Transgene/ChronTech/Inovio)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionNonstructural protein 4B modulatorsHepatitis C virus (HCV) nonstructural protein 3 modulators
TargetsHepatitis C virus (HCV) nonstructural protein 3Nonstructural protein 4B
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChrontech Pharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals IncTransgene SaChrontech Pharma Ab
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A